Skip to main content

Rydym wedi cadw rhai ffeiliau o'r enw cwcis ar eich dyfais. Y cwcis hyn yw:

  • Hanfodol ar gyfer y safle i weithio
  • Helpu i wella ein gwefan drwy gasglu ac adrodd gwybodaeth am sut rydych chi'n ei defnyddio

Hoffem hefyd arbed rhai cwcis i helpu i deilwra cyfathrebu.

BETA
Rydych yn edrych ar fersiwn wedi'i ddiweddaru o'r gwasanaeth hwn - bydd eich adborth yn ein helpu i'w wella.

Hysbysiad Gwybodaeth Ymlaen Llaw (PIN)

This is a Restricted Process. The supply of Construction Services for the Cell Gene Therapy Manufact

  • Cyhoeddwyd gyntaf: 17 Hydref 2017
  • Wedi'i addasu ddiwethaf: 17 Hydref 2017

Nid yw'r prynwr yn defnyddio'r wefan hon i weinyddu'r hysbysiad.

I gofnodi eich diddordeb neu gael gwybodaeth neu ddogfennau ychwanegol, darllenwch y cyfarwyddiadau yn Nhestun Llawn yr Hysbysiad. (NODER: Nid oes angen ymateb i Hysbysiadau Dyfarnu Contractau a Hysbysiadau Gwybodaeth Ymlaen Llaw fel arfer)

Cynnwys

Crynodeb

OCID:
Cyhoeddwyd gan:
Cell & Gene Therapy Catapult
ID Awudurdod:
AA58950
Dyddiad cyhoeddi:
17 Hydref 2017
Dyddiad Cau:
-
Math o hysbysiad:
Hysbysiad Gwybodaeth Ymlaen Llaw (PIN)
Mae ganddo ddogfennau:
Nac Ydi
Wedi SPD:
Nac Ydi
Mae ganddo gynllun lleihau carbon:
Nac Ydi

Crynodeb

With Phase 1 construction works due to be completed mid to late 2017, there is a business need to appoint a contractor to enable the following scope of works to be completed;

‘The design and construction of the fit out of 6nr clean room modules providing flexible space for Advanced Therapy Medicinal Product manufacture within an operational manufacturing facility’

Please see SQ & ITT documents for further information regarding project scope.

https://s2c.waxdigital.co.uk/Catapult/?Culture=en-GB

You are able to register your interest at the above tendering portal and obtain the necessary documents to enable you to register for the project.

Testun llawn y rhybydd

HYSBYSIAD GWYBODAETH YMLAEN LLAW - CYFNODOLYN SWYDDOGOL

Adran I: Awdurdod Contractio

I.1)

Enw, Cyfeiriad a Phwynt(iau) Cyswllt


Cell & Gene Therapy Catapult

12th Floor Guy's, Great Maze Pond

London

SE1 9ET

UK

ojeu@ct.catapult.org.uk

Mira Malic


ojeu@ct.catapult.org.uk





Blwch wedi'i dicio
Blwch heb ei dicio

I.2)

Math o Awdurdod contractio a'i Brif Weithgaredd neu Weithgareddau

Blwch wedi'i dicio

Private company limited by guarantee

Blwch heb ei dicio
Blwch heb ei dicio
Blwch heb ei dicio
Blwch heb ei dicio
Blwch heb ei dicio
Blwch heb ei dicio
Blwch heb ei dicio
Blwch heb ei dicio
Blwch heb ei dicio
Blwch heb ei dicio
Blwch wedi'i dicio

cell therapies

Na

Adran II.A: Amcan y Contract(GWAITH)

II.1)

Teitl a roddwyd i'r contract gan yr awdurdod contractio

This is a Restricted Process. The supply of Construction Services for the Cell Gene Therapy Manufacturing Centre Phase 2.

II.2)

Math o gontract a lleoliad y gwaith

Stevenage.


UKI21

II.3)

Mae'r hysbysiad hwn yn ymwneud â chytundeb fframwaith

Na

II.4)

Disgrifiad byr o natur a chwmpas y gwaith

With Phase 1 construction works due to be completed mid to late 2017, there is a business need to appoint a contractor to enable the following scope of works to be completed;

‘The design and construction of the fit out of 6nr clean room modules providing flexible space for Advanced Therapy Medicinal Product manufacture within an operational manufacturing facility’

Please see SQ & ITT documents for further information regarding project scope.

https://s2c.waxdigital.co.uk/Catapult/?Culture=en-GB

You are able to register your interest at the above tendering portal and obtain the necessary documents to enable you to register for the project.



II.5)

Geirfa Gaffael Gyffredin (CPV)

45000000

II.6)

Dyddiad y disgwylir i'r gweithdrefnau dyfarnu ddechrau a hyd y contract

  07 - 02 - 2018
  20 - 02 - 2018
  08 - 01 - 2019

II.7)

Contract wedi'i gwmpasu gan gytundeb caffael y llywodraeth (GPA)

Na

II.8)

Gwybodaeth ychwanegol

Please see SQ & ITT documents for further information regarding project scope.

https://s2c.waxdigital.co.uk/Catapult/?Culture=en-GB

You are able to register your interest at the above tendering portal and obtain the necessary documents to enable you to register for the project.

Cell & Gene Therapy reserves the right (acting in accordance with the Regulations) to:

— waive any requirements of this procurement process (to the extent permitted by law),

— request additional information or clarify information from Applicants in relation to any aspect of their response, — disqualify any Applicant that does not submit a compliant response in accordance with Cell &Gene Therapy instructions (see also below),

— withdraw any part of or the whole of this procurement process at any time or to re-invite responses on the same or any alternative basis,

— not award the whole of or a part of contract as a result of this procurement process, or

— make whatever changes it sees fit to the timetable, structure or content of the procurement process for any reason.

Furthermore, the Catapult reserves the right (acting in accordance with the Regulations) to reject or disqualify an Applicant where:

— a response is submitted late, is completed incorrectly, is incomplete or fails to meet Cell & Gene Therapy requirements which have been notified to Applicants,

— the Applicant is unable to satisfy the terms of Part V of the the Regulations at any stage during the procurement process,

— the Applicant is guilty of serious misrepresentation or fraud in relation to its application and/or any aspect of this procurement process,

— there is a change in identity, control, financial standing or other factor impacting on the ability and capacity of the Applicant to meet Cell & Gene Therapy requirements for any of the Works, supplies, or services advertised,and/or

— there is an actual or potential commercial, professional, financial or other conflict of interest arising between the interests of Cell & Gene Therapy and the Applicant.

The Applicant is solely responsible for all their costs and expenses incurred in connection with the preparation and submission of their responses at all stages of the procurement process. Under no circumstances will Cell &Gene Therapy be liable for any costs or expenses borne by or on behalf of any Applicant.

Clarifications and queries in respect of this Contract Notice or the pre-qualification questionnaire must be submitted in through the On-line Sourcing Tool (Wax Digital) using the Communications TAB. Direct emails,telephone calls or correspondence with Cell & Gene Therapy will not be permitted during the procurement of this opportunity.

Adran III: Gwybodaeth Gyfreithiol, Economaidd, Ariannol a Thechnegol

III.1)

Amodau sy'n ymwneud â'r contract

III.1.1)

Prif amodau ariannu a threfniadau talu a/neu gyfeiriad at y darpariaethau perthnasol sy'n eu rheoli

See draft terms within the SQ/ITT and associated supplementary information provided during the procurement exercise.

III.2)

Amodau ar gyfer cymryd rhan

III.2.1)

Contractau sydd wedi'u cadw

Na
Blwch heb ei dicio
Blwch heb ei dicio

Adran VI: Gwybodaeth Ategol

VI.1)

Mae'r contract yn ymwneud â phrosiect a/neu raglen a ariennir gan gronfa gymunedol

Na

VI.2)

Gwybodaeth ychwanegol

VI.3)

Gwybodaeth am fframwaith rheoleiddio cyffredinol




VI.4)

Dyddiad yr anfonwyd yr hysbysiad hwn

  13 - 10 - 2017

Codio

Categorïau nwyddau

ID Teitl Prif gategori
45000000 Gwaith adeiladu Adeiladu ac Eiddo Tiriog

Lleoliadau Dosbarthu

ID Disgrifiad
100 DU - I gyd

Cyfyngiadau Rhanbarthol ar y Rhybuddion

Mae’r prynwr wedi cyfyngu’r rhybuddion ar gyfer yr hysbysiad hwn i gyflenwyr yn y rhanbarthau canlynol.

ID Disgrifiad
Nid oes cyfyngiadau ar y rhybuddion ar gyfer yr hysbysiad hwn.

Ynglŷn â'r prynwr

Prif gyswllt:
ojeu@ct.catapult.org.uk
Cyswllt gweinyddol:
N/a
Cyswllt technegol:
N/a
Cyswllt arall:
N/a

Gwybodaeth bellach

Dyddiad Manylion
Nid oes unrhyw wybodaeth bellach wedi'i lanlwytho.

0800 222 9004

Mae'r llinellau ar agor rhwng 8:30am a 5pm o ddydd Llun i ddydd Gwener.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.